MedTrace Logo

Modified Adaptive Servoventilation (ASV) Compared to Conventional ASV

NCT01405313 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2017-03-20

Study results available
· View outcomes & findings →

Summary

This study will determine if modified adaptive servoventilation (ASV) is as effective as the conventional ASV in treating periodic breathing. The study will determine if the modified ASV reacts appropriately to reduce apneas and hypopneas and provides suitable levels of positive airway pressure compared to conventional ASV.

Conditions

  • Periodic Breathing
  • Breathing-Related Sleep Disorder

Interventions

DEVICE

Modified Adaptive Servoventilation Device

The modified ASV has a greater adaptive response to meet a target ventilation level that is constantly being assessed.

DEVICE

Conventional Adaptive Servoventilation device

Pressure support ventilation adapts to meet a target ventilation level that is constantly being assessed.

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Olaf Oldenburg, MD · Heart and Diabetes Centre, Ruhr University Bochum

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01405313 on ClinicalTrials.gov